Stem cells for skeletal muscle repair

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 366, Issue 1575, 2011, Pages 2297-2306

  Shadrach, Jennifer L ^a   Wagers, Amy J ^a  

^a Harvard University   (United States)

Author keywords

Muscle degeneration; Muscular dystrophy; Myogenesis; Sarcopenia; Satellite cell

Indexed keywords

CYTOLOGY; EMBRYONIC DEVELOPMENT; EXPERIMENTAL STUDY; MUSCLE; SKELETON;

DRUG DEVELOPMENT; HUMAN; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; STEM CELL; STEM CELL TRANSPLANTATION;

DRUG DISCOVERY; HUMANS; MUSCLE, SKELETAL; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 79960034993     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2011.0027     Document Type: Review

References (87)

1. Abdul-Ghani, M. A. & DeFronzo, R. A. 2010 Pathogenesis of insulin resistance in skeletal muscle. J. Biomed. Biotechnol. 2010, 476279. (doi:10.1155/2010/476279)
2. Mauro, A. 1961 Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9, 493-495. (doi:10.1083/ jcb.9.2.493)
3. Hawke, T. J. & Garry, D. J. 2001 Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91, 534-551.
4. Wagers, A. J. & Conboy, I. M. 2005 Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122, 659-667. (doi:10.1016/j.cell.2005.08.021)
5. Mitchell, K. J., Pannerec, A., Cadot, B., Parlakian, A., Besson, V., Gomes, E. R., Marazzi, G. & Sassoon, D. A. 2010 Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development. Nat. Cell Biol. 12, 257-266. (doi:10.1038/ncb2025)
6. Dellavalle, A. et al. 2007 Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol. 9, 255-267. (doi:10.1038/ncb1542)
7. Torrente, Y. et al. 2004 Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J. Clin. Invest.114, 182-195. (doi:10.1172/JCI20325)
8. Ferrari, G., Cusella-De Angelis, G., Coletta, M., Paolucci, E., Stornaiuolo, A., Cossu, G. & Mavilio, F.1998 Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279, 1528-1530. (doi:10.1126/science.279.5356.1528)
9. Sampaolesi, M. et al. 2003 Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301, 487-492. (doi:10.1126/science.1082254)
10. Sampaolesi, M. et al. 2006 Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444, 574-579. (doi:10.1038/nature05282)
11. Collins, C. A., Olsen, I., Zammit, P. S., Heslop, L., Petrie, A., Partridge, T. A. & Morgan, J. E. 2005 Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122, 289-301. (doi:10.1016/j.cell.2005.05.010)
12. Fukada, S. et al. 2004 Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody. Exp. Cell Res. 296, 245-255. (doi:10.1016/j.yexcr.2004.02.018)
13. Montarras, D., Morgan, J., Collins, C., Relaix, F., Zaffran, S., Cumano, A., Partridge, T. & Buckingham, M.2005 Direct isolation of satellite cells for skeletal muscle regeneration. Science 309, 2064-2067. (doi:10.1126/science.1114758)
14. Kuang, S., Kuroda, K., Le Grand, F. & Rudnicki, M. A.2007 Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 129, 999-1010. (doi:10.1016/j.cell.2007.03.044)
15. Tanaka, K. K., Hall, J. K., Troy, A. A., Cornelison, D. D., Majka, S. M. & Olwin, B. B. 2009 Syndecan-4- expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. Cell Stem Cell 4, 217-225. (doi:10.1016/j.stem.2009.01.016)
16. Sacco, A., Doyonnas, R., Kraft, P., Vitorovic, S. & Blau, H. M. 2008 Self-renewal and expansion of single transplanted muscle stem cells. Nature 456, 502-506. (doi:10.1038/nature07384)
17. Peault, B., Rudnicki, M., Torrente, Y., Cossu, G., Tremblay, J. P., Partridge, T., Gussoni, E., Kunkel, L. M. & Huard, J. 2007 Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol. Ther. 15, 867-877. (doi:10.1038/mt.sj.6300145)
18. Lepper, C., Conway, S. J. & Fan, C. M. 2009 Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements. Nature 460, 627-631. (doi:10.1038/nature08209)
19. Hettmer, S. & Wagers, A. J. 2010 Muscling in: uncovering the origins of rhabdomyosarcoma. Nat. Med. 16, 171-173. (doi:10.1038/nm0210-171)
20. Joe, A. W., Yi, L., Natarajan, A., Grand, F., So, L., Wang, J., Rudnicki, M. A. & Rossi, F. M. V. 2010 Le Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat. Cell Biol. 12, 153-163. (doi:10.1038/ncb2015)
21. Uezumi, A., Fukada, S., Yamamoto, N., Takeda, S. & Tsuchida, K. 2010 Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat. Cell Biol. 12, 143-152. (doi:10.1038/ncb2014)
22. Sherwood, R. I., Christensen, J. L., Conboy, I. M., Conboy, M. J., Rando, T. A., Weissman, I. L. & Wagers, A. J. 2004 Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell 119, 543-554. (doi:10.1016/j.cell.2004.10.021)
23. Sicinski, P., Geng, Y., Ryder-Cook, A. S., Barnard, E. A., Darlison, M. G. & Barnard, P. J. 1989 The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578-1580. (doi:10.1126/science.2662404)
24. Cerletti, M., Jurga, S., Witczak, C. A., Hirshman, M. F., Shadrach, J. L., Goodyear, L. J. & Wagers, A. J. 2008 Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell 134, 37-47. (doi:10.1016/j.cell.2008.05.049)
25. Decary, S., Hamida, C. B., Mouly, V., Barbet, J. P., Hentati, F. & Butler-Browne, G. S. 2000 Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul. Disord.10, 113-120. (doi:10.1016/S0960-8966(99)00093-0)
26. Sacco, A. et al. 2010 Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell 143, 1059-1071. (doi:10.1016/j. cell.2010.11.039)
27. Melone, M. A., Peluso, G., Galderisi, U., Petillo, O. & Cotrufo, R. 2000 Increased expression of IGF-binding protein-5 in Duchenne muscular dystrophy (DMD) fibroblasts correlates with the fibroblast-induced downregulation of DMD myoblast growth: An in vitro analysis. J. Cell. Physiol. 185, 143-153. (doi:10.1002/1097-4652 (200010)185:1,143::AID-JCP14.3.0.CO;2-U)
28. De Paepe, B., Schroder, J.M., Martin, J. J., Racz, G. Z. & De Bleecker, J. L. 2004 Localization of the alphachemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies. Neuromuscul. Disord. 14, 265-273. (doi:10.1016/j.nmd.2004.01.001)
29. Ratajczak, M. Z., Majka, M., Kucia, M., Drukala, J., Pietrzkowski, Z., Peiper, S. & Janowska-Wieczorek, A.2003 Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 21, 363-371. (doi:10.1634/stemcells.21-3-363)
30. Wood, M. J., Gait, M. J. & Yin, H. 2010 RNA-targeted splice-correction therapy for neuromuscular disease. Brain 133, 957-972. (doi:10.1093/brain/awq002)
31. Strothotte, S. et al. 2010 Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J. Neurol. 257, 91-97. (doi:10.1007/s00415-009-5275-3)
32. van der Ploeg, A. T. et al. 2010 A randomized study of alglucosidase alfa in late-onset Pompe's disease. N. Engl. J. Med. 362, 1396-1406. (doi:10.1056/ NEJMoa 0909859)
33. Fukuda, T., Roberts, A., Plotz, P. H. & Raben, N. 2007 Acid alpha-glucosidase deficiency (Pompe disease). Curr. Neurol. Neurosci. Rep. 7, 71-77. (doi:10.1007/s11910-007-0024-4)
34. Schoser, B., Hill, V. & Raben, N. 2008 Therapeutic approaches in glycogen storage disease type II/Pompe Disease. Neurotherapeutics 5, 569-578. (doi:10.1016/j. nurt.2008.08.009)
35. Partridge, T. A., Morgan, J. E., Coulton, G. R., Hoffman, E. P. & Kunkel, L. M. 1989 Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337, 176-179. (doi:10.1038/337176a0)
36. Skuk, D. & Tremblay, J. P. 2003 Myoblast transplantation: the current status of a potential therapeutic tool for myopathies. J. Muscle Res. Cell. Motil. 24, 285-300. (doi:10.1023/A:1025425823322)
37. Conboy, M. J., Cerletti, M., Wagers, A. J. & Conboy, I. M. 2010 Immuno-analysis and FACS sorting of adult muscle fiber-associated stem/precursor cells. Methods Mol. Biol. 621, 165-173. (doi:10.1007/978-1-60761-063-2_11)
38. Gilbert, P. M. et al. 2010 Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science 329, 1078-1081. (doi:10.1126/science.1191035)
39. Connelly, J. P., Barker, J. C., Pruett-Miller, S. & Porteus, M. H. 2010 Gene correction by homologous recombination with zinc finger nucleases in primary cells from a mouse model of a generic recessive genetic disease. Mol. Ther. 18, 1103-1110. (doi:10.1038/mt.2010.57)
40. Zou, J. et al. 2009 Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5, 97-110. (doi:10.1016/j.stem.2009.05.023)
41. U.S.Census Bureau, Population Division. Interim projections by age, sex, race and Hispanic origin. See www.census.gov/population/www/projections/usinterimproj/
42. Mathers, C. D. & Loncar, D. 2006 Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3, e442. (doi:10.1371/journal.pmed.0030442)
43. Thompson, L. V. 2009 Age-related muscle dysfunction. Exp. Gerontol. 44, 106-111. (doi:10.1016/j.exger.2008.05.003)
44. Pahor, M. et al. 2006 Effects of a physical activity intervention on measures of physical performance: results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J. Gerontol. 61, 1157-1165.
45. Brack, A. S., Bildsoe, H. & Hughes, S. M. 2005 Evidence that satellite cell decrement contributes to preferential decline in nuclear number from large fibres during murine age-related muscle atrophy. J. Cell Sci. 118, 4813-4821. (doi:10.1242/jcs.02602)
46. Brack, A. S., Conboy, M. J., Roy, S., Lee, M., Kuo, C. J., Keller, C. & Rando, T. A. 2007 Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317, 807-810. (doi:10.1126/science.1144090)
47. Conboy, I. M., Conboy, M. J., Smythe, G. M. & Rando, T. A. 2003 Notch-mediated restoration of regenerative potential to aged muscle. Science 302, 1575-1577. (doi:10.1126/science.1087573)
48. Conboy, I. M. & Rando, T. A. 2005 Aging, stem cells and tissue regeneration: lessons from muscle. Cell Cycle 4, 407-410. (doi:10.4161/cc.4.3.1518)
49. Shefer, G., Van de Mark, D. P., Richardson, J. B. & Yablonka-Reuveni, Z. 2006 Satellite-cell pool size does matter: defining the myogenic potency of aging skeletal muscle. Dev. Biol. 294, 50-66. (doi:10.1016/j.ydbio.2006.02.022)
50. Collins, C. A., Zammit, P. S., Ruiz, A. P., Morgan, J. E. & Partridge, T. A. 2007 A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells 25, 885-894. (doi:10.1634/stemcells.2006-0372)
51. Bischoff, R. (ed) 1994 The satellite cell and muscle regeneration. New York, NY: McGraw-Hill.
52. Degens, H. 2010 The role of systemic inflammation in age-related muscle weakness and wasting. Scand. J. Med. Sci. Sports 20, 28-38. (doi:10.1111/j.1600-0838.2009.01018.x)
53. Shefer, G., Rauner, G., Yablonka-Reuveni, Z. & Benayahu, D. 2010 Reduced satellite cell numbers and myogenic capacity in aging can be alleviated by endurance exercise. PloS ONE. 5, e13307. (doi:10.1371/journal.pone.0013307)
54. Bortoli, S., Renault, V., Eveno, E., Auffray, C., Butler- Browne, G. & Pietu, G. 2003 Gene expression profiling of human satellite cells during muscular aging using cDNA arrays. Gene 321, 145-154. (doi:10.1016/j.gene.2003.08.025)
55. Conboy, I. M., Conboy, M. J., Wagers, A. J., Girma, E. R., Weissman, I. L. & Rando, T. A. 2005 Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433, 760-764. (doi:10.1038/ nature03260)
56. Ames, B. N. 2004 Delaying the mitochondrial decay of aging. Ann. NY Acad. Sci. 1019, 406-411. (doi:10.1196/annals.1297.073)
57. Golden, T. R., Hinerfeld, D. A. & Melov, S. 2002 Oxidative stress and aging: beyond correlation. Aging Cell 1, 117-123. (doi:10.1046/j.1474-9728.2002.00015.x)
58. Hasty, P., Campisi, J., Hoeijmakers, J., van Steeg, H. & Vijg, J. 2003 Aging and genome maintenance: lessons from the mouse? Science 299, 1355-1359. (doi:10.1126/science.1079161)
59. Pietrangelo, T., Puglielli, C., Mancinelli, R., Beccafico, S., Fano, G. & Fulle, S. 2009 Molecular basis of the myogenic profile of aged human skeletal muscle satellite cells during differentiation. Exp. Gerontol. 44, 523-531. (doi:10.1016/j.exger.2009.05.002)
60. Zhu, C. H., Mouly, V., Cooper, R. N., Mamchaoui, K., Bigot, A., Shay, J. W., Di Santo, J. P., Butler-Browne, G. S. & Wright, W. E. 2007 Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell 6, 515-523. (doi:10.1111/j.1474-9726.2007.00306.x)
61. Kadi, F. & Ponsot, E. 2010 The biology of satellite cells and telomeres in human skeletal muscle: effects of aging and physical activity. Scand. J. Med. Sci. Sports 20, 39-48. (doi:10.1111/j.1600-0838.2009.00966.x)
62. Carlson, M. E., Hsu, M. & Conboy, I. M. 2008 Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454, 528-532. (doi:10.1038/nature07034)
63. Brack, A. S., Conboy, I. M., Conboy, M. J., Shen, J. & Rando, T. A. 2008 A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2, 50-59. (doi:10.1016/j.stem.2007.10.006)
64. Sarkar, D. & Fisher, P. B. 2006 Molecular mechanisms of aging-associated inflammation. Cancer Lett. 236, 13-23. (doi:10.1016/j.canlet.2005.04.009)
65. McGeer, E. G. & McGeer, P. L. 2003 Inflammatory processes in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry. 27, 741-749. (doi:10.1016/ S0278-5846(03)00124-6)
66. McGeer, P. L. & McGeer, E. G. 2002 Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26, 459-470. (doi:10.1002/mus.10191)
67. McGeer, P. L. & McGeer, E. G. 2004 Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat. Disord. 10(Suppl. 1), S3-S7. (doi:10.1016/j.parkreldis.2004.01.005)
68. Di Iorio, A., Abate, M., Di Renzo, D., Russolillo, A., Battaglini, C., Ripari, P., Saggini, R., Paganelli, R. & Abate, G. 2006 Sarcopenia: age-related skeletal muscle changes from determinants to physical disability. Int. J. Immunopathol. Pharmacol. 19, 703-719.
69. Serrano, A. L., Baeza-Raja, B., Perdiguero, E., Jardi, M. & Munoz-Canoves, P. 2008 Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 7, 33-44. (doi:10.1016/j.cmet.2007.11.011)
70. Haddad, F., Zaldivar, F., Cooper, D. M. & Adams, G. R.2005 IL-6-induced skeletal muscle atrophy. J. Appl. Physiol. 98, 911-917. (doi:10.1152/japplphysiol.01026.2004)
71. Tidball, J.G. 2005 Inflammatory processes inmuscle injury and repair. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R345-R353. (doi:10.1152/ajpregu.00454.2004)
72. Harman, D. 1957 Prolongation of the normal life span by radiation protection chemicals. J. Gerontol. 12, 257-263.
73. Cohen, H. J., Pieper, C. F., Harris, T., Rao, K. M. & Currie, M. S. 1997 The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J. Gerontol. 52, M201-M208.
74. Schaap, L. A., Pluijm, S. M. F., Deeg, D. J. H. & Visser, M. 2006 Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am. J. Med. 119, 52.e9-52.e17. (doi:10.1016/j.amjmed.2005.10.049)
75. Giresi, P. G., Stevenson, E. J., Theilhaber, J., Koncarevic, A., Parkington, J., Fielding, R. A. & Kandarian, S. C. 2005 Identification of a molecular signature of sarcopenia. Physiol. Genomics. 21, 253-263. (doi:10.1152/physiolgenomics.00249.2004)
76. Eggan, K. 2008 Using stem cells and reprogramming to understand disease. Regen. Med. 3, 799-801. (doi:10.2217/17460751.3.6.799)
77. Maherali, N. & Hochedlinger, K. 2008 Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3, 595-605. (doi:10.1016/j. stem.2008.11.008)
78. Stadtfeld, M., Maherali, N., Breault, D. T. & Hochedlinger, K. 2008 Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2, 230-240. (doi:10.1016/j.stem.2008.02.001)
79. Takahashi, K. & Yamanaka, S. 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. (doi:10.1016/j.cell.2006.07.024)
80. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. & Yamanaka, S. 2007 Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872. (doi:10.1016/j.cell.2007.11.019)
81. Park, I. H. et al. 2008 Disease-specific induced pluripotent stem cells. Cell 134, 877-886. (doi:10.1016/j.cell.2008.07.041)
82. Dimos, J. T. et al. 2008 Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221. (doi:10.1126/science.1158799)
83. Barberi, T., Bradbury, M., Dincer, Z., Panagiotakos, G., Socci, N. D. & Studer, L. 2007 Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat. Med. 13, 642-648. (doi:10.1038/nm1533)
84. Mizuno, Y. et al. 2010 Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. Faseb J. 24, 2245-2253. (doi:10.1096/fj.09-137174)
85. Darabi, R., Baik, J., Clee, M., Kyba, M., Tupler, R. & Perlingeiro, R. C. 2009 Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy. Exp. Neurol. 220, 212-216. (doi:10.1016/j.expneurol.2009.08.002)
86. Darabi, R., Gehlbach, K., Bachoo, R. M., Kamath, S., Osawa, M., Kamm, K. E., Kyba, M. & Perlingeiro, R. C. R. 2008 Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat. Med. 14, 134-143. (doi:10.1038/nm1705)
87. Chang, H. et al. 2009 Generation of transplantable, functional satellite-like cells from mouse embryonic stem cells. Faseb J. 23, 1907-1919. (doi:10.1096/fj.08-123661)